Erbay Demir
Erbay Demir has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Canan Eryıldız
Department of Medical Microbiology, Trakya University Hospital, Edirne, Türkiye
3 shared publicationsFatma Elif Usturalı Keskin
Department of Pathology, Trakya University Hospital, Edirne, Türkiye
2 shared publicationsMuhsin Koten
Department of Otorhinolaryngology, Kirklareli Training And Research Hospital, Kırklareli, Türkiye
2 shared publicationsSelis Gülseven Güven
Department of Otorhinolaryngology, Trakya University Hospital, Edirne, Türkiye
2 shared publications- Selis Gülseven Güven
Department of Otorhinolaryngology, Trakya University Hospital, Edirne, Türkiye
2 shared publications - Cem Uzun
Koç University, Istanbul, Turkiye
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 54 (2) , 135-142
Effectiveness of topical intranasal curcumin in the experimentally induced allergic rhinitis model in rats (revised)
Curcumin, a flavonoid derived from turmeric, has demonstrated antioxidant, anti-inflammatory, and antiallergic effects. This study evaluated the therapeutic efficacy of intranasal curcumin in an allergic rhinitis (AR) rat model. Forty rats were randomized into four groups: a sham control, an AR model with no treatment (negative control), an AR model treated with intranasal mometasone furoate (positive control), and an AR model treated with intranasal curcumin. Allergic symptoms (sneezing, itching, nasal discharge) were evaluated by both unblinded and blinded observers. Serum Ovalbumin (OVA)-specific IgE levels were measured using ELISA. Nasal mucosal histopathology (edema, cilia loss, goblet cell hyperplasia, inflammation, eosinophilia) was assessed by light microscopy. Intranasal curcumin significantly improved histopathological findings and reduced allergic symptoms, with efficacy comparable to steroid treatment. It alleviates AR symptoms and inflammation, suggesting a promising, low-cost alternative for AR management.
- 1 March 2026
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 54 (2) , 135-142
Open AccessEffectiveness of topical intranasal curcumin in the experimentally induced allergic rhinitis model in rats (revised)
Curcumin, a flavonoid derived from turmeric, has demonstrated antioxidant, anti-inflammatory, and antiallergic effects. This study evaluated the therapeutic efficacy of intranasal curcumin in an allergic rhinitis (AR) rat model. Forty rats were randomized into four groups: a sham control, an AR model with no treatment (negative control), an AR model treated with intranasal mometasone furoate (positive control), and an AR model treated with intranasal curcumin. Allergic symptoms (sneezing, itching, nasal discharge) were evaluated by both unblinded and blinded observers. Serum Ovalbumin (OVA)-specific IgE levels were measured using ELISA. Nasal mucosal histopathology (edema, cilia loss, goblet cell hyperplasia, inflammation, eosinophilia) was assessed by light microscopy. Intranasal curcumin significantly improved histopathological findings and reduced allergic symptoms, with efficacy comparable to steroid treatment. It alleviates AR symptoms and inflammation, suggesting a promising, low-cost alternative for AR management.
- Open Access
- 1 March 2026
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 54 (2) , 180
Corrigendum to: Effectiveness of topical intranasal Curcumin in the experimentally induced allergic rhinitis model in rats
In the above-mentioned article, the authors wish to correct several points related to reporting consistency, statistical terminology, and citation accuracy. These corrections do not affect the results or the conclusions of the study.
- 1 March 2026
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 54 (2) , 180
Open AccessCorrigendum to: Effectiveness of topical intranasal Curcumin in the experimentally induced allergic rhinitis model in rats
In the above-mentioned article, the authors wish to correct several points related to reporting consistency, statistical terminology, and citation accuracy. These corrections do not affect the results or the conclusions of the study.
- Open Access
- 1 January 2026
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 54 (1) , 1-7
Effectiveness of topical intranasal curcumin in the experimentally induced allergic rhinitis model in rats
Curcumin, a flavonoid derived from turmeric, has demonstrated antioxidant, anti-inflammatory, and anti-allergic effects. This study evaluated the therapeutic efficacy of intranasal curcumin in an allergic rhinitis (AR) rat model. Forty rats were randomized into five groups: a Sham control, an AR model with no treatment (negative control), an AR model treated with intranasal mometasone furoate (positive control), and an AR model treated with intranasal curcumin. Allergic symptoms (sneezing, itching, nasal discharge) were evaluated by both unblinded and blinded observers. Serum ovalbumin (OVA)-specific IgE levels were measured using ELISA. Nasal mucosal histopathology (edema, cilia loss, goblet cell hyperplasia, inflammation, eosinophilia) was assessed by light microscopy. Intranasal curcumin significantly improved histopathological findings and reduced allergic symptoms, with efficacy comparable to steroid treatment. Intranasal curcumin alleviated allergic rhinitis symptoms and inflammation, suggesting a promising, low-cost alternative for AR management.
- 1 January 2026
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 54 (1) , 1-7
Open AccessEffectiveness of topical intranasal curcumin in the experimentally induced allergic rhinitis model in rats
Curcumin, a flavonoid derived from turmeric, has demonstrated antioxidant, anti-inflammatory, and anti-allergic effects. This study evaluated the therapeutic efficacy of intranasal curcumin in an allergic rhinitis (AR) rat model. Forty rats were randomized into five groups: a Sham control, an AR model with no treatment (negative control), an AR model treated with intranasal mometasone furoate (positive control), and an AR model treated with intranasal curcumin. Allergic symptoms (sneezing, itching, nasal discharge) were evaluated by both unblinded and blinded observers. Serum ovalbumin (OVA)-specific IgE levels were measured using ELISA. Nasal mucosal histopathology (edema, cilia loss, goblet cell hyperplasia, inflammation, eosinophilia) was assessed by light microscopy. Intranasal curcumin significantly improved histopathological findings and reduced allergic symptoms, with efficacy comparable to steroid treatment. Intranasal curcumin alleviated allergic rhinitis symptoms and inflammation, suggesting a promising, low-cost alternative for AR management.
- Open Access
- 14 March 2022
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 10 (1) , 108-114
Cochlear Implant Surgery Experiences of a Tertiary Health Center in the Thrace Region
- 14 March 2022
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 10 (1) , 108-114
Open AccessCochlear Implant Surgery Experiences of a Tertiary Health Center in the Thrace Region